Skip to main
DOCS

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 22%
Buy 39%
Hold 28%
Sell 6%
Strong Sell 6%

Bulls say

Doximity has reported a significant growth of over 100% in its POC and formulary offerings, indicating strong demand and successful expansion in its service portfolio. The company's stock has shown resilience with a modest increase of 3.2% since September 8, suggesting positive market sentiment. Furthermore, the guidance for the second quarter appears attainable, with indications of potential upside, which positions Doximity favorably for future growth.

Bears say

Doximity Inc. is experiencing negative financial outlooks primarily due to the uncertain economic environment, which has prompted its pharmaceutical clients to issue downward revisions for fiscal years 2023 and 2024. Additionally, the company's shares are perceived as expensive compared to its software peers, making them susceptible to volatility should performance expectations not be met. Lastly, heightened scrutiny on Doximity's financial results intensifies the potential for disappointment if the company fails to deliver positive outcomes or raise guidance.

Doximity (DOCS) has been analyzed by 18 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 39% recommend Buy, 28% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Buy based on their latest research and market trends.

According to 18 analysts, Doximity (DOCS) has a Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.